Timeline to symptomatic Alzheimer’s disease in people with Down syndrome as assessed by amyloid-PET and tau-PET: a longitudinal cohort study

Christian, PhD, B. T., and S. Hartley, PhD. Timeline to Symptomatic Alzheimer’s Disease in People With Down Syndrome As Assessed by Amyloid-PET and Tau-PET: A Longitudinal Cohort Study.
Schworer, E. K., Zammit, M. D., Wang, J., Handen, B. L., Betthauser, T., Laymon, C. M., Tudorascu, D. L., Cohen, A. D., Zaman, S. H., Ances, B. M., Mapstone, M., Head, E., Christian, B. T., Hartley, S. L., & Alzheimer’s Biomarker Consortium–Down Syndrome (ABC–DS) (2024). Timeline to symptomatic Alzheimer’s disease in people with Down syndrome as assessed by amyloid-PET and tau-PET: a longitudinal cohort study. The Lancet. Neurology, 23(12), 1214–1224. https://doi.org/10.1016/S1474-4422(24)00426-5